Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. The fund was up 11.20% in the ...

Studied across thousands of patients and supported by hundreds of clinical publications, the TCAR pioneer has continually delivered positive outcomes through minimally invasive techniques ...

Boston Scientific has agreed to acquire Silk Road Medical for around $1.26bn, adding the US-based carotid artery device specialist to its roster. Boston Scientific will pay $27.50 in cash per ...

SUNNYVALE, Calif., March 05, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it ...

Silk Road Medical's TCAR platform has regulatory approvals in the U.S., Japan, and China, showing potential for revenue growth in underpenetrated markets like Asia-Pacific. wildpixel/iStock via ...

The products sold by Sunnyvale, Calif.-based Silk Road Medical are the only devices commercially available for use during the TCAR procedure. Silk Road went public in 2019, raising more than $120 ...

Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. Baron Discovery Fund (the Fund ...

“Silk Road Medical, Inc (NASDAQ:SILK) sells medical devices used in minimally invasive transcarotid artery revascularization (TCAR) procedures. The company’s TCAR device allows placement of a ...

Silk Road Medical Celebrates Milestone Of 100,000 Transcarotid Artery Revascularization (TCAR) Procedures ...

“Silk Road Medical, Inc (NASDAQ:SILK) ... The company’s TCAR device allows placement of a stent in the carotid artery to provide better blood flow to the brain, ...

Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. Baron Discovery Fund (the Fund) ...